Abstract
An understanding of the basic elements of neurotransmission in the brain is an important foundation for any consideration of the clinical use and future development of antidepressants. However, attempts to describe the influences of drugs on brain and neuronal function have become increasingly complex, and it is now clear that neuronal processes are complex molecular events involving multiple control factors. The brain consists of approximately 100 million neurons, which account for half of the brain's volume, with the other half being made up of glial cells. New insights into the function of glial cells, the influence of phosphorylation on neuronal functions, and the regulation of genetic functions in synthesizing neuronal proteins have enhanced our appreciation of the complexity of neural function in the brain. Glial cells play an important role in recycling and conserving the neurotransmitters glutamate and GABA and also have an important effect on neurons in the brain via glial cell line-derived neurotrophic factor (GDNF). The basic function of neurons is to convey electrical signals in a highly organized and integrated way. The dominant means of neuron-to-neuron communication or transmission occurs by means of specific chemicals (i.e., neurotransmitters). Neuronal communication is a complex process that involves neurotransmitter storage and release, neurotransmitter inactivation, receptors, G proteins, and second messengers. A number of neuronal mechanisms have been identified that are thought to play important roles in the etiology of major depressive disorder (e.g., the serotonin transporter mechanism); an increasing understanding of the neuronal mechanisms that underlie psychiatric disorders will help to guide future drug development.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aschner M, Allen JW, Kimelberg HK, LoPachin RM, Streit WJ (1999) Glial cells in neurotoxicity development. Annu Rev Pharmacol Toxicol 39:151–173
Attwell D (1994) Neurobiology: glia and neurons in dialogue. Nature 369:707–708
Bacci A, Verderio C, Pravettoni E, Matteoli M (1999) The role of glial cells in synaptic function. Philos Trans R Soc Lond B Biol Sci 354:403–409
Baker R, Llinas R (1971) Electronic coupling between neurons in the rat mesencephalic nucleus. J Physiol 212:45–63
Baraban JM, Worley PF, Snyder SH (1989) Second messenger systems and psychoactive drug action: focus on the phosphoinositide system and lithium. Am J Psychiatry 146:1251–1259
Belmaker RH, Livine A, Agam G, Moscovich DG, Grisaru N, Schreiber G, Avissar S, Danon A, Kofman O (1990) Role of inositol-1-phosphatase inhibition in the mechanism of action of lithium. Pharmacol Toxicol 66(suppl 3):76–83
Blakely RD, Berson HE, Fremeau RT Jr, Caron MG, Peek MM, Prince HK, Bradley CC (1991) Cloning and expression of a functional serotonin transporter from rat brain. Nature 354:66–70
Blakely RD, Ramamoorthy S, Qian Y, Schroeter S, Bradley CC (1997) Regulation of anti-depressant-sensitive serotonin transporters. In: Reith MEA (ed) Neurotransmitter transporters: structure, function, and regulation. Humana Press, Totowa, NJ, pp 29–72
Blakely RD, Ramamoorthy S, Schroeter S, Qian Y, Apparsundaram S, Galli A, DeFelice LJ (1998) Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol.Psychiatry 44:169–178
Bohn MC (1999) A commentary on glial cell line-derived neurotrophic factor (GDNF): from a glial secreted molecule to gene therapy. Biochem Pharmacol 57:135–142
Caldecott-Hazard S, Morgan DG, DeLeon-Jones F, Overstreet DH, Janowsky D (1991) Clinical and biochemical aspects of depressive disorders. II: transmitter/receptor theories. Synapse 9:251–301
Catterall WA (1999) Interactions of presynaptic Ca2+ channels and snare proteins in neurotransmitter release. In: Rudy B, Seeburg P (eds) Molecular and functional diversity of ion channels and receptors. The New York Academy of Sciences, New York, pp 144–159
Clapham DE, Neer EJ (1993) New roles for G-protein beta gamma-dimers in transmembrane signaling. Nature 365:403–406
Cooper DM, Mons N, Karpen JW (1995) Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature 374:421–424
Cooper JR, Bloom FE, Roth RH (1996) The biochemical basis of neuropharmacology, 7th edition. Oxford University Press, New York
Cornell-Bell AH, Finkbeiner SM (1991) Ca2+ waves in astrocytes. Cell Calcium 12:185–204
Cornell-Bell AH, Finkbeiner SM, Cooper MS, Smith SJ (1990) Glutamate induced calcium waves in cultured astrocytes: long-range glial signaling. Science 247:470–473
Corvalan V, Cole R, de Vellis J, Hagiwara S (1990) Neuronal modulation of calcium channel activity in cultured rat astrocytes. Proc Natl Acad Sci U S A 87:4345–4348
Danoff SK, Ross CA (1994) The inositol trisphosphate receptor gene family: implications for normal and abnormal brain function. Prog Neuropsychopharmacol Biol Psychiatry 18:1–16
Enkvist MOK, McCarthy KD (1992) Activation of protein kinase C blocks astroglial gap junction communication and inhibits the spread of calcium waves. J Neurochem 59:519–526
Furth PA, St Onge L, Boger H, Gruss P, Gossen M, Kistner A, Bujard H, Hennighausen L (1994) Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci U S A 91:9302–9306
Galli A, Petersen CI, deBlaquiere M, Blakely RD, DeFelice LJ (1997) Drosophila serotonin transporters have voltage-dependent uptake coupled to a serotonin-gated ion channel. J Neurosci 17:3401–3411
Gegelashvili G, Schousboe A (1997) High affinity glutamate transporters: regulation of expression and activity. Mol Pharmacol 52:6–15
Gilman AG (1989) G proteins and regulation of adenylyl cyclase. JAMA 262:1819–1825
Grady S, Marks MJ, Wonnacott S, Collins AC (1992) Characterization of nicotinic receptor-mediated [3H] dopamine release from synaptosomes prepared from mouse striatum. J Neurochem 59:848–856
Grondin R, Gash DM (1998) Glial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson’s disease. J Neurol 245:35–42
Guldberg HC, Mardsen CA (1975) Catechol-O-methyl transferase: pharmacological aspects and physiological role. Pharmacol Rev 27:135–206
Haga K, Haga T (1992) Activation by G protein βy subunits of agonist-or light-dependent phosphorylation of muscarinic acetylcholine receptors and rhodopsin. J Biol Chem 267:2222–2227
Hausdorff WP, Caron MG, Lefkowitz RJ (1990) Turning off the signal: desensitization of β-adrenergic receptor function. FASEB J 4:2881–2889
Hokin LE, Dixon JF (1993) The phosphoinositide signalling system. I. historical background. II. Effects of lithium on the accumulation of second messenger inositol 1,4,5-trisphosphate in brain cortex slices. Prog Brain Res 98:309–315
Hughes RL (1990) Cyclosporine-related central nervous system toxicity in cardiac transplantation [letter]. N Engl J Med 323:420–421
Inagaki N, Wada H (1994) Histamine and prostanoid receptors on glial cells. Glia 11:102–109
Joels M, de Kloet ER (1994) Mineralcorticoid and glucocorticoid receptors in the brain: implications for ion permeability and transmitter systems. Prog Neurobiol 43:1–36
Jursky F, Tamura S, Tamura A, Mandiyan S, Nelson H, Nelson N (1994) Structure, function and brain localization of neurotransmitter transporters. J Exp Biol 196:283–295
Kanai Y, Smith CP, Hediger MA (1994) A new family of neurotransmitter transporters: the high-affinity glutamate transporters. FASEB J 8:1450–1459
Kanner BI, Bendahan A, Pantanowitz S, Su H (1994) The number of amino acid residues in hydrophilic loops connecting transmembrane domains of the GABA transporter GAT-1 is critical for its function. FEBS Lett 356:191–194
Kasai H, Petersen OH (1994) Spatial dynamics of second messengers: IP3 and cAMP as long-range and associative messengers. Trends Neurosci 17:95–101
Kelly RB (1999) An introduction to the nerve terminal. In: Bellen HJ (ed) Neruotransmitter release. Oxford University Press, Oxford, pp 1–33
Kenakin T (1995a) Agonist-receptor efficacy I: mechanisms of efficacy and receptor promiscuity. Trends Pharmacol Sci 16:188–192
Kenakin T (1995b) Agonist-receptor efficacy II: agonist trafficking of receptor signals. Trends Pharmacol Sci 16:232–238
Kilts CD (1994) Recent pharmacologic advances in antidepressant therapy. Am J Med 97(suppl 6A):3S–12S
Kofman O, Belmaker RH (1993) Ziskind-Somerfeld Research Award 1993. Biochemical, behavioral, and clinical studies of the role of inositol in lithium treatment and depression. Biol Psychiatry 34:839–852
Korn H, Sotelo C, Crepel F (1973) Electronic coupling between neurons in rat lateral vestibular nucleus. Exp Brain Res 16:255–275
Krantz DE, Chaudhry FA, Edwards RH (1999) Neurotransmitter transporters. In: Bellen HJ (ed) Neurotransmitter release. Oxford University Press, Oxford, pp 145–207
Lai J, Bilsky EJ, Rothman RB, Porreca F (1994) Treatment with antisense oligodeoxynucleotide to the opioid delta receptor selectively inhibits delta 2-agonist antinociception. Neuroreport 5:1049–1052
Lapchak PA (1998) A preclinical development strategy designed to optimize the use of glial cell line-derived neurotrophic factor in the treatment of Parkinson’s disease. Mov Disord 13(suppl 1):49–54
Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region [see comments]. Science 274:1527–1531
Lesch KP, Mossner R (1998) Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders? Biol Psychiatry 44:179–192
Lester HA, Cao Y, Mager S (1996) Listening to neurotransmitter transporters. Neuron 17:807–810
Levitan IB, Kacmarek LK (1997) The neuron: cell and molecular biology, 2nd edition. New York, Oxford University Press
Llinas R, Baker R, Sotelo C (1974) Electronic coupling between neurons in the cat inferior olive. J Neurophysiol 37:560–571
LoTurco JJ, Kriegstein AR (1991) Clusters of coupled neuroblasts in embryonic neocortex. Science 252:563–566
Lovinger DM (1997) Alcohols and neurotransmitter gated ion channels: past, present and future. Naunyn Schmiedebergs Arch Pharmacol 356:267–282
Lucas JJ, Hen R (1995) New players in the 5-HT receptor field: genes and knockouts. Trends Pharmacol Sci 16:246–252
Lyson T, Ermel LD, Belshaw PJ, Alberg DG, Schreiber SL, Victor RG (1993) Cyclosporine-and FK506-induced sympathetic activation correlates with calcineurin-mediated inhibition of T-cell signaling. Circ Res 73:596–602
MacDermott AB, Role LW, Siegelbaum SA (1999) Presynaptic ionotropic receptors and the control of transmitter release. Annu Rev Neurosci. 22:443–485
Mannisto PT, Ulmanen I, Lundstrom K, Taskinen J, Tenhunen J, Tilgmann C, Kaakkola S (1992) Characteristics of catechol O-methyl-transferase (COMT) and properties of selective COMT inhibitors. Prog Drug Res 39:291–350
Marshall IC, Taylor CW (1993) Regulation of inositol 1,4,5-trisphosphate receptors. J Exp Biol 184:161–182
Martin DL (1992) Synthesis and release of neuroactive substances by glial cells. Glia 5:81–94
McGeer PL, McGeer EG (1998) Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions. Alzheimer Dis Assoc Disord 12(suppl 2):S1–S6
McKnight GS (1991) Cyclic AMP second messenger systems. Curr Opin Cell Biol 3:213–217
Melcangi RC, Magnaghi V, Martini L (1999) Steroid metabolism and effects in central and peripheral glial cells. J Neurobiol 40:471–483
Melikian HE, Ramamoorthy S, Tate CG, Blakely RD (1996) Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition. Mol Pharmacol 50:266–276
Nalepa I (1994) The effect of psychotropic drugs on the interaction of protein kinase C with second messenger systems in the rat cerebral cortex. Pol J Pharmacol 46:1–14
Narahashi T, Aistrup GL, Marszalec W, Nagata K (1999) Neuronal nicotinic acetylcholine receptors: a new target site of ethanol. Neurochem Int 35:131–141
Nelson N (1998) The family of Na+/Cl-neurotransmitter transporters. J Neurochem 71:1785–1803
Nishizuka Y (1995) Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9:484–496
Oswald I, Brezinova V, Dunleavy DLF (1972) On the slowness of action of tricyclic antide-pressant drugs. Br J Psychiatry 120:673–677
Otero GC, Merrill JE (1994) Cytokine receptors on glial cells. Glia 11:117–128
Parthasarathy L, Vadnal RE, Parthasarathy R, Devi CS (1994) Biochemical and molecular properties of lithium-sensitive myo-inositol monophosphatase. Life Sci 54:1127–1142
Paul IA, Nowak G, Layer RT, Popik P, Skolnick P (1994) Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. J Pharmacol Exp Ther 269:95–102
Pitcher JA, Inglese J, Higgins JB, Arriza JL, Casey PJ, Kim C, Benovic JL, Kwatra MM, Caron MG, Lefkowitz RJ (1992) Role of beta gamma subunits of G proteins in targeting the beta-adrenergic receptor kinase to membrane-bound receptors. Science 257:1264–1267
Poitry-Yamate CL, Poitry S, Tsacopoulos M (1995) Lactate released by Muller glial cells is metabolized by photoreceptors from mammalian retina. J Neurosci 15:5179–5191
Premont RT, Inglese J, Lefkowitz RJ (1995) Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J 9:175–182
Rahamimoff R, Butkevich A, Duridanova D, Ahdut R, Harari E, Kachalsky SG (1999) Multitude of ion channels in the regulation of transmitter release. Philos Trans R Soc Lond B Biol Sci 354:281–288
Raivich G, Jones LL, Werner A, Bluthmann H, Doetschmann T, Kreutzberg GW (1999) Molecular signals for glial activation: pro-and anti-inflammatory cytokines in the injured brain. Acta Neurochir Suppl (Wien) 73:21–30
Ransom BR, Sontheimer H (1992) The neurophysiology of glial cells. J Clin Neurophysiol 9:224–251
Rens-Domiao S, Hamm HE (1995) Structural and functional relationships of heterotrimeric G-proteins. FASEB J 9:1059–1066
Robinson SR, Hampson E, Munro MN, Vaney DI (1993) Unidirectional coupling of gap junctions between neuroglia. Science 262:1072–1074
Ronde P, Nichols RA (1998) High calcium permeability of serotonin 5-HT3 receptors on presynaptic nerve terminals from rat striatum. J Neurochem 70:1094–1103
Saarma M, Sariola H (1999) Other neurotrophic factors: glial cell line-derived neurotrophic factor (GDNF). Microsc Res Tech 45:292–302
Saudou F, Amara DA, Dierich A, LeMeur M, Ramboz S, Segu L, Buhot MC, Hen R (1994) Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 265:1875–1878
Schlag BD, Vondrasek JR, Munir M, Kalandadze A, Zelenaia OA, Rothstein JD, Robinson MB (1998) Regulation of the glial Na+-dependent glutamate transporters by cyclic AMP analogs and neurons. Mol Pharmacol 53:355–369
Shank RP, William JB, Charles WA (1989) Glutamine and 2-oxoglutarate as metabolic precursors of the transmitter pools of glutamate and GABA: correlation of regional uptake by rat brain synaptosomes. Neurochem Res 16:29–34
Shepard GM (1994) Neurobiology, 2nd edition. New York, Oxford University Press
Shinohara K, Hiruma H, Funabashi T, Kimura F (2000) GABAergic modulation of gap junction communication in slice cultures of the rat suprachiasmatic nucleus. Neuroscience 96:591–596
Silvia CP, King GR, Lee TH, Xue ZY, Caron MG, Ellinwood EH (1994) Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine. Mol Pharmacol 46:51–57
Singer TP, Ramsay RR (1995) Monoamine oxidases: old friends hold many surprises. FASEB J 9:605–610
Sontheimer H (1994) Voltage dependent ion channels in glial cells. Glia 11:156–172
Standifer KM, Chien CC, Wahlestedt C, Brown GP, Pasternak GW (1994) Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor. Neuron 12:805–810
Stephens DN, Kehr W, Duka T (1986) Anxiolytic and anxiogenic β-carbolines: tools for the study of anxiety mechanisms. In: Biggio G, Costa E (eds) GABAergic transmission and anxiety. Raven, New York, pp 91–106
Swanson RA, Liu J, Miller JW, Rothstein JD, Farrell K, Stein BA, Longuemare MC (1997) Neuronal regulation of glutamate transporter subtype expression in astrocytes. J Neurosci 17:932–940
Tallman JF, Cassela JV, White G, Gallager DW (1999) GABAA receptors: diversity and its implications for CNS disease. The Neuroscientist 5:351–361
Tecott LH, Sun LM, Akana SF, Strack AM, Lowenstein DH, Dallman MF, Julius D (1995) Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 374:542–546
Thiel G. (1995) Recent breakthroughs in neurotransmitter release: paradigm for regulated exocytosis? News in Physiological Science 10:42–46
Thomas KR, Capecchi MR (1990) Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development. Nature 346:847–850
Tsacopoulos M, Magistretti PJ (1996) Metabolic coupling between glia and neurons. J Neurosci 16:877–885
Vardimon L, Ben-Dror I, Avisar N, Oren A, Shiftan L (1999) Glucocorticoid control of glial gene expression. J Neurobiol 40:513–527
Wahlestedt C, Pich EM, Koob GF, Yee F, Heilig M (1993) Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science 259:528–531
Walsh DA, Van Patten SM (1994) Multiple pathway signal transduction by the cAMP-dependent protein kinase. FASEB J 8:1227–1236
Wartiovaara K, Hytonen M, Vuori M, Paulin L, Rinne J, Sariola H (1998) Mutation analysis of the glial cell line-derived neurotrophic factor gene in Parkinson’s disease. Exp Neurol 152:307–309
Watkins SS, Epping-Jordan MP, Koob GF, Markou A. (1999) Blockade of nicotine self-administration with nicotinic antagonists in rats. Pharmacol Biochem Behav 62:743–751
Wolfe BB, Harden TK, Sporn JR, Molinoff PB (1978) Presynaptic modulation of beta adrenergic receptors in rat cerebral cortex after treatment with antidepressants. J Pharmacol Exp Ther 207:446–457
Wonnacott S (1997) Presynaptic nicotinic ACh receptors. Trends in Neuroscience 20:92–98
Yakel JL (1997) Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription. Trends Pharmacol Sci. 18:124–134
Yeomans J, Baptista M (1997) Both nicotinic and muscarinic receptors in ventral tegmental area contribute to brain-stimulation reward. Pharmacol Biochem Behav 57:915–921
Yudosky SC, Hales RE (eds) (2002) The American Psychiatric Press Textbook of Neuro-psychiatry, 4th edn. American Psychiatric Publishing. Washington, DC, pp 1123–1147
Zahs KR (1998) Heterotypic coupling between glial cells of the mammalian central nervous system. Glia 24:85–96
Zhang B, Ramaswami M (1999) Synaptic vesicle endocytosis and recycling. In: Bellen HJ (ed) Neurotransmitter release. Oxford University Press, Oxford, pp 389–431
Zhou LW, Zhang SP, Qin ZH, Weiss B (1994) In vivo administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor messenger RNA inhibits D2 dopamine receptor-mediated behavior and the expression of D2 dopamine receptors in mouse striatum. J Pharmacol Exp Ther 268:1015–1023
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Horst, W.D. (2004). Biochemical and Physiological Processes in Brain Function and Drug Actions. In: Preskorn, S.H., Feighner, J.P., Stanga, C.Y., Ross, R. (eds) Antidepressants: Past, Present and Future. Handbook of Experimental Pharmacology, vol 157. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18500-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-18500-7_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62135-2
Online ISBN: 978-3-642-18500-7
eBook Packages: Springer Book Archive